Indication
Allergy
35 clinical trials
44 products
2 drugs
Product
DBV712Clinical trial
A 52 Week, Multi-center, Randomized, Double-blind Placebo-controlled Study to Assess the Clinical Efficacy and Safety of Ligelizumab (QGE031) in Decreasing the Sensitivity to Peanuts in Patients With Peanut AllergyStatus: Terminated, Estimated PCD: 2023-08-11
Product
PlaceboClinical trial
A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of Epicutaneous Immunotherapy With DBV712 250 μg in 4-7-year-old Children With Peanut Allergy (VITESSE)Status: Recruiting, Estimated PCD: 2025-03-01
Product
ligelizumabProduct
5-grass mix SLIT-dropsClinical trial
A Randomised, Parallel-group, Double-blind, Placebo-controlled Phase III Trial Assessing the Efficacy and Safety of 5-grass Mix SLIT-drops in Adults With Grass Pollen-induced RhinoconjunctivitisStatus: Completed, Estimated PCD: 2023-09-26
Product
remibrutinibClinical trial
A One Month, Investigator and Participant Blinded Study to Investigate the Efficacy and Safety of Remibrutinib (LOU064) at Multiple Dose Levels in Adult Participants With Peanut AllergyStatus: Recruiting, Estimated PCD: 2026-04-29
Product
placeboProduct
House Dust Mite ExtractClinical trial
A Randomized, Double Blind, Placebo-controlled, Multiple-dose, Parallel Phase Ⅰ Study to Evaluate Safety and Compare the Immune Stimulating Efficacy of "DF19001" in Dermatophagoides Farinae Sensitized Allergic Rhinitis VolunteersStatus: , Estimated PCD: 2024-12-21
Product
ADX-102Product
LevocetirizineClinical trial
A Pilot, Open, Monocenter, Randomized Two Parallel Groups, Clinical Efficacy Trial: Comparison Continuous Versus on Demand Regimen of Treatment With Levocetirizine 5 mg Oral Tablets, Once a Day, in Adults Suffering From Persistent Allergic Rhinitis (PER) Over 6 MonthsStatus: Completed, Estimated PCD: 2006-06-01
Clinical trial
A RDPC, Prospective, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of SCIT in Patients With Rhinitis With or Without Mild to Moderate Asthma Sensitized to Cupressaceae and Grasses.Status: Recruiting, Estimated PCD: 2023-12-01
Product
10,000 MG01Product
30000 MG01 +10000 T521Clinical trial
Randomized, Double-blinded, Placebo-controlled, Prospective, Multicenter Trial to Evaluate the Efficacy and Safety of SIC in Subjects With Mild/Moderate Asthma and Rhinitis/Rhinoconjunctivitis Sensitized to D.Pteronyssinus and/or D. FarinaeStatus: Recruiting, Estimated PCD: 2024-01-01
Product
10,000 MM09Product
30,000 MM09Product
Cetirizine HClClinical trial
A Randomized, Open-Label, Single-Dose, Five-Period Crossover, Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg Administered in Healthy Adult Male and Female SubjectsStatus: Not yet recruiting, Estimated PCD: 2023-12-15
Product
ZyrtecClinical trial
A Randomized, Double-Blinded, Placebo-Controlled, Prospective, Multicenter CT to Evaluate Efficacy and Safety of Subcutaneous Immunotherapy in Subjects With Rhinitis With/Without Mild to Moderate Asthma Sensitized to Olive and Grass PollenStatus: Recruiting, Estimated PCD: 2025-10-01
Product
30000 MG01 + 10000 T517Product
10,000 MG01 + 10,000 T517Clinical trial
Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma - Outcomes From a Multinational Register StudyStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Product
SQ SLITClinical trial
Efficacy and Safety of the SQ Tree Sublingual Immunotherapy Tablet in Children and Adolescents With Moderate to Severe Allergic Rhinitis and/or Conjunctivitis Induced by Pollen From Birch and Trees Belonging to the Birch Homologous GroupStatus: Completed, Estimated PCD: 2023-07-31
Product
SQ tree SLITClinical trial
A Study of Long-term (12-24 Weeks) Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Protocol No. P06333)Status: Completed, Estimated PCD: 2010-12-01
Product
Mometasone furoateClinical trial
Mechanistic Trial of Dupilumab in Adults With House Dust Mite-associated Asthma Using an Aeroallergen Challenge ChamberStatus: Recruiting, Estimated PCD: 2026-11-01
Product
DupilumabClinical trial
SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATIONStatus: Recruiting, Estimated PCD: 2030-12-31
Product
ImmunomodulationClinical trial
Documentation of Efficacy for Intralymphatic Allergen Immunotherapy in a Phase III Randomized, Parallel Group, Double Blind Placebo-controlled Multisite Field TrialStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Product
Polvac Grass+RyeProduct
SalineClinical trial
Adding Biological Therapy to Asthmatic Patients on Allergen Immunotherapy to House Dust MitesStatus: Not yet recruiting, Estimated PCD: 2026-10-01
Product
omalizumabClinical trial
Efficacy and Safety of Washed Microbiota Transplantation for Allergic Rhinitis: A Randomized, Double-blind, Placebo-controlled StudyStatus: Not yet recruiting, Estimated PCD: 2029-06-01
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Single-center Clinical Trial of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic RhinitisStatus: Recruiting, Estimated PCD: 2025-09-01
Product
GanciclovirProduct
Ganciclovir SimulantProduct
MometasoneClinical trial
A Randomised, Controlled Trial to Determine if BCG Immunisation at Birth Reduces Allergy and Infection in InfantsStatus: Active (not recruiting), Estimated PCD: 2024-06-30
Drug
BCGClinical trial
Nasal Irrigation With Chinese Herbal Medicine as an Adjunctive Treatment in Allergic Rhinitis: Phase 2 Randomized, Double-blinded, Placebo-controlled TrialStatus: Completed, Estimated PCD: 2022-04-30
Clinical trial
Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter/Multinational, Efficacy and Safety Study of Desloratadine 5 mg in the Treatment of Subjects With Allergic Rhinitis Who Meet the Criteria for Intermittent Allergic Rhinitis (IAR)Status: Completed, Estimated PCD: 2007-11-01
Product
DesloratadineDrug
VarlilumabClinical trial
A Phase II Trial to Evaluate the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic PatientsStatus: Recruiting, Estimated PCD: 2027-01-11
Product
AntibioticProduct
Edible CaramelClinical trial
Exposure to Vaginal Microbiome in C-section Infants at High-risk for Allergies - A Pilot StudyStatus: Recruiting, Estimated PCD: 2025-01-01
Product
C-sectionClinical trial
Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Protocol No.P06332)Status: Completed, Estimated PCD: 2010-10-01
Clinical trial
Study on the Mechanism of ZhenQiFuZheng in the Treatment of Allergic Rhinitis Based on Intestinal Flora and MetabolitesStatus: Not yet recruiting, Estimated PCD: 2025-06-01
Product
ZhenQi FuZheng granulesClinical trial
Randomized Double Blind Placebo Controlled Trial of Grass Pollen Immunotherapy Using a Cluster RegimeStatus: Completed
Clinical trial
Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control StudyStatus: Active (not recruiting), Estimated PCD: 2024-05-07
Clinical trial
Harnessing the Beneficial Non-specific Effects of Measles-mumps-rubella Vaccine in Children on Infection With Unrelated Pathogens and Allergic Diseases - a Single-centre Phase IV RCT With a Factorial DesignStatus: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: A Pilot Study. (Up-dosing Study)Status: Completed, Estimated PCD: 2008-01-01
Product
Alutard SQClinical trial
Nationwide Research on the Rewilding of Kindergarten Yards - VahvistuStatus: Recruiting, Estimated PCD: 2027-08-30
Product
BiodiversityClinical trial
The Regulatory Mechanism of EGR2 Mediated by miR-150-5p on Allergic RhinitisStatus: , Estimated PCD: 2023-02-01
Product
EGR2Clinical trial
A Phase 2 Multi-centre Randomized Double-blind Placebo-controlled Parallel Group Study to Examine the Effects of 24 Weeks Tezepelumab 210 mg sc q4wks on Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic AsthmaStatus: Not yet recruiting, Estimated PCD: 2024-12-30
Product
TezepelumabClinical trial
Is the Effect of Systemic Steroids Treating Pollen Induced Allergic Rhinitis Mainly Due to a Placebo EffectStatus: Completed, Estimated PCD: 2022-06-20
Product
MethylPREDNISoloneProduct
NaCl